Search research articles
Contact Us
Filters
Showing results (751-760 of 764) with videos related to
Page
of 77
Sort By:
Cancer Research
|
December 2, 2022
Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity
Hannah L Williams, Andressa Dias Costa, Jinming Zhang, et al.
JCI Insight
|
November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer population
Lynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.
Nature Communications
|
May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
Samuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
JAMA Oncology
|
November 4, 2017
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma
Zhi Rong Qian, Douglas A Rubinson, Jonathan A Nowak, et al.
Cancer Discovery
|
September 28, 2015
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K Brastianos, Scott L Carter, Sandro Santagata, et al.
Nature Cancer
|
May 26, 2023
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias
Ricardo de Matos Simoes, Ryosuke Shirasaki, Sondra L Downey-Kopyscinski, et al.
Nature Genetics
|
October 6, 2009
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J Bass, Hideo Watanabe, Craig H Mermel, et al.
Nature
|
March 25, 2011
Initial genome sequencing and analysis of multiple myeloma
Michael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Cell
|
December 10, 2021
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
Srivatsan Raghavan, Peter S Winter, Andrew W Navia, et al.
Nature Communications
|
June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma
Pratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Page
of 77
Search research articles
Search
Showing results (751-760 of 764) with videos related to
Sort By:
Page
of 77
Cancer Research
|
December 2, 2022
Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity
Hannah L Williams, Andressa Dias Costa, Jinming Zhang, et al.
JCI Insight
|
November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer population
Lynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.
Nature Communications
|
May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
Samuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
JAMA Oncology
|
November 4, 2017
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma
Zhi Rong Qian, Douglas A Rubinson, Jonathan A Nowak, et al.
Cancer Discovery
|
September 28, 2015
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K Brastianos, Scott L Carter, Sandro Santagata, et al.
Nature Cancer
|
May 26, 2023
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias
Ricardo de Matos Simoes, Ryosuke Shirasaki, Sondra L Downey-Kopyscinski, et al.
Nature Genetics
|
October 6, 2009
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J Bass, Hideo Watanabe, Craig H Mermel, et al.
Nature
|
March 25, 2011
Initial genome sequencing and analysis of multiple myeloma
Michael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Cell
|
December 10, 2021
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
Srivatsan Raghavan, Peter S Winter, Andrew W Navia, et al.
Nature Communications
|
June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma
Pratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Page
of 77